Principal Investigator
Prof. Dr. Emel Emregül
Researcher
Tuva Atasever, Astronaut 027
Flight
Galactic 07
Date
2024
Organization
Ankara University
Ankara University – METABOLOM
The main purpose of this study was to better understand the molecular mechanisms that occur in the human body as a result of a suborbital spaceflight through metabolomic analysis of biological samples collected from TUA’s astronaut and data received from the blood plasma transcriptome.
Principal Investigator
Dr. Vladimir Ivkovic and Ms. JoAnna Pollonais
Researcher
Tuva Atasever, Astronaut 027
Flight
Galactic 07
Date
2024
Organization
Massachusetts General Hospital and Harvard Medical School
BEACON-R (Behavioral, Affective, Cognitive and Neurophysiological Responses to Spaceflight)
Part of BEACON-R saw Tuva wear NINscan during the Galactic 07 mission. This was the first spaceflight for NINscan: A custom developed brain and physiological monitoring system originally developed for NASA and used in extreme environments, including parabolic flight.
Principal Investigator
Dr. Steven Collicot
Flight
Galactic 07
Date
2024
Organization
Purdue University
Purdue University School of Aeronautics and Astronautics – Rotational Slosh
When spacecraft are accelerating in space, such as during a pointing maneuver, reorientation burns for docking, or to transfer to a new trajectory, it sets the liquid in propellant tanks in motion. After the thruster firing ends, the liquid motion slows down in the zero-gravity environment. This experiment studied the rate of damping of liquid motion after a rotational maneuver.
Principal Investigator
Dr. John Marshall and Mr. Alex Rubin
Researcher
Tuva Atasever, Astronaut 027
Flight
Galactic 07
Date
2024
Contractor
Axiom Space
Axiom Space and TUA – Suborbital Testing of Insulin Pens
This experiment serves as a stepping stone to support astronauts with insulin-dependent diabetes and demonstrates a capability necessary for maintenance therapy and hyperglycemic states in insulin dependent people with diabetes.